IndraLab

Statements


| 2

reach
"Together, our study demonstrated for the first time that KIF15 enhances the glycolytic capacity of PC through the recruitment of USP10 and PGK1, and that the KIF15/USP10/PGK1 axis may serve as an effective therapeutic agent for PC."

reach
"The MS and Co-IP assay indicated that KIF15 recruited and enhanced the binding between PGK1 and USP10."